A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

Edward Pan, Susan B. Mitchell, Jerry S. Tsai

Journal of Neuro-Oncology. 2008;88(3):353-357

Link2 Link3

Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma

Mehran Yusuf, Beatrice Ugiliweneza, Mark Amsbaugh, Maxwell Boakye, Brian Williams, Megan Nelson, Eyas M. Hattab, Shiao Woo, Eric Burton

Oncology. 2018;95(1):39-42

ATIM-46. A MULTICENTER, PHASE I, TRIAL OF RADIATION, TEMOZOLOMIDE AND RRx-001 FOLLOWED BY MAINTENANCE TEMOZOLOMIDE WITH OR WITHOUT RRx-001 IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS

Robert Aiken, Howard Fine, Nicholas Butowski

Neuro-Oncology. 2019;21(Supplement_6):vi11-vi12

SYST-08. A phase II trial of concurrent Sunitinib, Temozolomide and Radiation Therapy followed by adjuvant Temozolomide for newly diagnosed Glioblastoma patients with an unmethylated MGMT gene promoter (A01-M121-11A, McG1132)

Mame Daro Faye, Siham Sabri, Paula De Robles, Raman Agnihotram, Alexander Torres-Vasquez, Jacob Easaw, Bassam Abdulkarim

Neuro-Oncology Advances. 2021;3(Supplement_4):iv10-iv10

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

J. Uhm

Yearbook of Neurology and Neurosurgery. 2011;2011:143-144

ACTR-03. FINAL RESULTS OF A PHASE II STUDY OF HYPOFRACTIONATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN PATIENTS OVER 70 YEARS OLD WITH NEWLY DIAGNOSED GLIOBLASTOMA

Mehran Yusuf, Jeremy Gaskins, Shiao Woo, Eric Burton

Neuro-Oncology. 2019;21(Supplement_6):vi12-vi12

A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter

M.D. Faye, S. Sabri, P. De Robles, R. Agnihotram, A. Torres-Vasquez, V. Panet-Raymond, G. Shenouda, L. Souhami, J. Esaw, B.S. Abdulkarim

International Journal of Radiation Oncology*Biology*Physics. 2022;114(3):S169

4: A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter (A01-M121-11A, MCG1132)

Mame Daro Faye, Siham Sabri, Paula De Robles, Jacob Easaw, Raman Agnihotram, Alexander Torres-Vasquez, Valerie Panet-Raymond, George Shenouda, Luis Souhami, Bassam Abdulkarim

Radiotherapy and Oncology. 2022;174:S5

RADT-18. NEOADJUVANT (PRE RADIOTHERAPY) TEMOZOLOMIDE FOLLOWED BY RADIATION THERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME

Chinmaykumar Prajapati, Maitrik Mehta, U Suryanarayan Kunikullaya

Neuro-Oncology. 2021;23(Supplement_6):vi45-vi45